Berry Oncology Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • Series B2

  • Latest Deal Amount
  • $7.74M

  • Investors
  • 9

Berry Oncology General Information

Description

Provider of genomic testing products and services intended to detect and screen cancers. The company's products and services include companion diagnostics, response monitoring and prognosis prediction of both targeted and immune therapies, providing patients with local or metastatic cancers with a complete system of genomic testing products and services.

Contact Information

Website
www.berryoncology.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • R & D Building, No. 7, No. 33, Donghu Road
  • Digital Fujian Industrial Park, Changle District
  • Fuzhou, Fujian
  • China
+86 0591
Primary Industry
Diagnostic Equipment
Other Industries
Laboratory Services (Healthcare)
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • R & D Building, No. 7, No. 33, Donghu Road
  • Digital Fujian Industrial Park, Changle District
  • Fuzhou, Fujian
  • China
+86 0591

Berry Oncology Timeline

2022202320242025
Financing Round

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Berry Oncology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B2) 01-Oct-2021 $7.74M Completed Generating Revenue
3. Early Stage VC (Series B) 01-Jul-2021 Completed Generating Revenue
2. Early Stage VC (Series A1) 01-Oct-2020 $29.5M $151M Completed Generating Revenue
1. Early Stage VC (Series A) 01-Jan-2018 $121M $121M Completed Generating Revenue
To view Berry Oncology’s complete valuation and funding history, request access »

Berry Oncology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Provider of genomic testing products and services intended to detect and screen cancers. The company's products and serv
Diagnostic Equipment
Fuzhou, China

Birmingham, AL
 

Louisville, CO
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Berry Oncology Competitors (27)

One of Berry Oncology’s 27 competitors is CirculoGene, a Venture Capital-Backed company based in Birmingham, AL.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CirculoGene Venture Capital-Backed Birmingham, AL
Biodesix Formerly VC-backed Louisville, CO
Ezra (Diagnostic Equipment) Venture Capital-Backed New York, NY
UE LifeSciences Venture Capital-Backed Philadelphia, PA
Foundation Medicine Formerly VC-backed Cambridge, MA
You’re viewing 5 of 27 competitors. Get the full list »

Berry Oncology Patents

  • 3

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 3

    Pending

  • Expiring in next 12 mo

Berry Oncology Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20240347131-A1 Cancer detection model and construction method therefor, and reagent kit Pending 17-Aug-2021
EP-4372751-A4 Cancer detection model and construction method therefor, and reagent kit Pending 17-Aug-2021
EP-4372751-A1 Cancer detection model and construction method therefor, and reagent kit Pending 17-Aug-2021 G16B20/10

Berry Oncology Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
China Merchants Capital Asset Manager Minority
CICC Capital PE/Buyout Minority
Efund Asset Management Asset Manager Minority
Fujian Huaxing Venture Capital Venture Capital Minority
Xiamen C&D Corporation Corporation Minority
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Berry Oncology FAQs

  • When was Berry Oncology founded?

    Berry Oncology was founded in 2017.

  • Where is Berry Oncology headquartered?

    Berry Oncology is headquartered in Fuzhou, China.

  • What industry is Berry Oncology in?

    Berry Oncology’s primary industry is Diagnostic Equipment.

  • Is Berry Oncology a private or public company?

    Berry Oncology is a Private company.

  • What is the current valuation of Berry Oncology?

    The current valuation of Berry Oncology is .

  • What is Berry Oncology’s current revenue?

    The current revenue for Berry Oncology is .

  • How much funding has Berry Oncology raised over time?

    Berry Oncology has raised $259M.

  • Who are Berry Oncology’s investors?

    China Merchants Capital, CICC Capital, Efund Asset Management, Fujian Huaxing Venture Capital, and Xiamen C&D Corporation are 5 of 9 investors who have invested in Berry Oncology.

  • Who are Berry Oncology’s competitors?

    CirculoGene, Biodesix, Ezra (Diagnostic Equipment), UE LifeSciences, and Foundation Medicine are some of the 27 competitors of Berry Oncology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »